Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Skin Diseases, Papulosquamous”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT01382784
What this trial is testing

Psoriasis and the Risk of Cardiovascular Disease. A Prospective Study

Who this might be right for
PsoriasisCardiovascular Disease
Oslo University Hospital 100
Not applicableStudy completedNCT03168347
What this trial is testing

Assessing Patient Confidence in Biologic Medications

Who this might be right for
Psoriasis
Wake Forest University Health Sciences 400
Early research (Phase 1)UnknownNCT04091698
What this trial is testing

Clinical and Biochemical Assessment of the Effect of Topical Use of Coenzyme Q10 Versus Topical Corticosteroid in Management of Symptomatic Oral Lichen Planus: Randomized Controlled Clinical Trial

Who this might be right for
Oral Lichen Planus
Cairo University 34
Large-scale testing (Phase 3)Study completedNCT03478787
What this trial is testing

Risankizumab Versus Secukinumab for Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
AbbVie 327
Not applicableStudy completedNCT06101706
What this trial is testing

Assessment of Fatigue in Psoriatic Arthritis and Cutaneous Psoriasis Patients

Who this might be right for
Psoriatic ArthritisPsoriasis
Centre Hospitalier Henri Duffaut - Avignon 33
Not applicableStudy completedNCT04149587
What this trial is testing

Brodalumab (SILIQ®) in Psoriasis Participants With Inadequate Response to Their Current Biologic Agent Regimen

Who this might be right for
Psoriasis
Bausch Health Americas, Inc. 252
Post-approval studies (Phase 4)Study completedNCT02425826
What this trial is testing

Efficacy and Safety of Apremilast in Subjects With Moderate Plaque Psoriasis.

Who this might be right for
Parapsoriasis
Amgen 221
Not applicableNot Yet RecruitingNCT07626788
What this trial is testing

Pentoxifylline Add-On Therapy for Mild-to-Moderate Plaque Psoriasis

Who this might be right for
Psoriasis
Wasuchon Chaichan 140
Early research (Phase 1)Study completedNCT01258088
What this trial is testing

Safety Study of Ointment for the Treatment of Plaque-type Psoriasis

Who this might be right for
Plaque-type Psoriasis
Pfizer 16
Not applicableEnded earlyNCT02881229
What this trial is testing

Vulvar Mucosal Specialty Clinic Chart Review

Who this might be right for
Vulvar DiseaseLichen SclerosusLichen Planus+1 more
Northwestern University 719
Not applicableStudy completedNCT04745429
What this trial is testing

Non-pharmacological Mitigation of Psoriasis

Who this might be right for
PsoriasisStressInflammation+4 more
Medical University of Lodz 38
Not applicableNot Yet RecruitingNCT07398651
What this trial is testing

Apremilast and Adalimumab in Psoriatic Arthritis Patients

Who this might be right for
Psoriatic ArthritisUltrasound AssessmentTNF
Tanta University 60
Early research (Phase 1)Looking for participantsNCT03816345
What this trial is testing

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Who this might be right for
Autoimmune DiseaseCrohn DiseaseDermatomyositis+11 more
National Cancer Institute (NCI) 300
Not applicableStudy completedNCT02188654
What this trial is testing

Metformin in Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
University of Alexandria 56
Large-scale testing (Phase 3)Study completedNCT02559622
What this trial is testing

Evaluation of Cardiovascular Risk Markers in Psoriasis Patients Treated With Secukinumab

Who this might be right for
Psoriasis
Novartis Pharmaceuticals 151
Not applicableStudy completedNCT03831646
What this trial is testing

Clinical, Psychological and Genetic Characteristics in Dermatological Patients

Who this might be right for
Atopic DermatitisPsoriasis
Astana Medical University 150
Testing effectiveness (Phase 2)WithdrawnNCT04115020
What this trial is testing

Low Dose Naltrexone for Chronic Pain in Osteoarthritis and Inflammatory Arthritis

Who this might be right for
OsteoarthritisArthritis, RheumatoidArthritis, Psoriatic
Brigham and Women's Hospital
Not applicableStudy completedNCT00658827
What this trial is testing

Analysis of Birth Outcomes of Swedish, Danish and Finnish Women Exposed to Remicade With Inflammatory Bowel Disease, Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and Psoriasis

Who this might be right for
Inflammatory Bowel Disease
Janssen Biotech, Inc. 370
Not applicableStudy completedNCT00293709
What this trial is testing

Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Dermatologists

Who this might be right for
Arthritis, PsoriaticPsoriasisSkin Diseases, Papulosquamous
Pfizer 129
Large-scale testing (Phase 3)Looking for participantsNCT06663332
What this trial is testing

A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants

Who this might be right for
Crohns DiseaseColitis, UlcerativeArthritis, Psoriatic+1 more
Janssen Research & Development, LLC 196
Next Page